...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: is any one going tmr? Questions?

just back


RVX Investor Relations

1:17 PM (0 minutes ago)
 
 
 
 
 
 
 
 
 
 
 
 
 
 

"Yes, I would be happy to add your questions to the list for the AGM".

 

fyi : the 3 questions mentioned have been sent

Share
New Message
Please login to post a reply